Wellington Management Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Wellington Management Group’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-394,587	Closed	-$4.34M	–	2239
2016 Q1	$4.34M	Sell	394,587 -14,326	-4%	-$127K	﹤0.01%	1397
2015 Q4	$3.76M	Buy	408,913 +45,177	+12%	+$378K	﹤0.01%	1446
2015 Q3	$2.52M	Buy	363,736 +46,201	+15%	+$396K	﹤0.01%	1560
2015 Q2	$3.12M	Sell	317,535 -9,170	-3%	-$83.5K	﹤0.01%	1549
2015 Q1	$2.9M	Hold	326,705	–	–	﹤0.01%	1595
2014 Q4	$2.86M	Buy	326,705 +64,108	+24%	+$519K	﹤0.01%	1594
2014 Q3	$1.81M	Buy	262,597 +885	+0.3%	+$5.3K	﹤0.01%	1700
2014 Q2	$1.38M	Sell	261,712 -51,300	-16%	-$250K	﹤0.01%	1754
2014 Q1	$1.42M	Hold	313,012	–	–	﹤0.01%	1759
2013 Q4	$1.58M	Buy	313,012 +39,500	+14%	+$190K	﹤0.01%	1753
2013 Q3	$1.39M	Buy	273,512 +63,274	+30%	+$352K	﹤0.01%	1734
2013 Q2	$1.04M	Buy	+210,238	New	+$1M	﹤0.01%	1755

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group's SCLN Position: Q2 2016 in Review

Wellington Management Group sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2016, closing a stake of 394,587 shares — an estimated $4.34M sold.

Wellington Management Group first reported a position in SCLN in Q2 2013 and held it in 12 quarters. The position peaked at $4.34M in Q1 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q2 2016.

Wellington Management Group reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Wellington Management Group sold 394,587 Sciclone Pharmaceuticals Inc shares in Q2 2016, an estimated $4.34M.
Wellington Management Group first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
Wellington Management Group's Sciclone Pharmaceuticals Inc position peaked at $4.34M in Q1 2016.
151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2016.

Based on Wellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.